Release Date: 31/07/18 16:03 Summary: Activity and Cashflow Reports for the June 2018 Quarter Price Sensitive: Yes Download Document 464.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%